1. Home

Latest news

logo uniQure
Clinical Update on First Patients in Phase I/II Clinical Trial Gene Therapy for the Treatment of Huntington’s Disease
Convegno Annuale LIRH 2021 - locandina
LIRH Annual Conference: Towards the Cure of Huntington Disease - December 3, 2021
farmaci
SOM3355: a new drug for the treatment of the "chorea" symptom in Huntington's disease
Giornata Mondiale per la Prevenzione del Suicidio
Huntington's and Suicide - 10 September: World Suicide Prevention Day
Confermata la validità dell'indagine epidemiologica LIRH
International confirmation of the number of HD affected in Italy (LIRH estimate)
La mente prima del corpo
The mind fragility of Huntington Disease patients in a recent publication
logo rare barometer
Rare Barometer 2021: patients opinion on the future of rare diseases
Yoga e malattia di Huntington Giorgia
Huntington Disease and Yoga: online classes for caregivers
Malattie Rare e Malattia di Huntington: gli impegni che i pazienti chiedono alle Istituzioni, europee e nazionali, per rispondere ai loro bisogni
Rare Diseases and Huntington's Disease: Patients' Appeal to Policy Makers
La prima parte dell’arruolamento nella sperimentazione con ATM-130 per l'Huntington si è conclusa con successo e lo studio arriverà presto in Europa.
Buone notizie da UniQure sulla sperimentazione con ATM-130 per la malattia di Huntington
Malattia di Huntington: Interruzione somministrazione di tominersen in Generation HD1 - Domande e Risposte
Huntington's disease: Tominersen dosing interruption in Generation HD1 - Questions and Answers
Si interrompe la somministrazione di tominersen nella sperimentazione Generation HD1 di Roche per la malattia di Huntington
Si interrompe la somministrazione di tominersen nella sperimentazione Generation HD1 di Roche per la malattia di Huntington
Huntington, Diamo Colore alle Nostre Voci! - Giornata Mondiale Malattie Rare 2021
Huntington Disease (HD): Let’s color our voices! - Rare Disease Day 2021
Updates on AMT-130 gene therapy for the treatment of Huntington's disease
Updates on AMT-130 gene therapy for the treatment of Huntington's disease
Neurodegeneration: a mechanism links Huntington's to other diseases
A common neurodegeneration marker for Huntington's, Parkinson's, and Alzheimer's disease
Proof-HD' trial with Pridopidine in Huntington's disease
The first European patients in the Phase 3 'Proof-HD' trial with Pridopidine in Huntington's disease are from Italy and Germany
Healthe-RND: verso un modello di telemedicina specifico per Huntington e malattie rare neurodegenerative
Healthe-RND: Toward a telemedicine model for Huntington's and rare neurodegenerative diseases
LIRH Annual Conference 2020: The Current treatment Perspectives for Huntington Disease
LIRH Annual Conference 2020: The Current treatment Perspectives for Huntington Disease
Giornata Internazionale delle Persone con (dis)abilità 2020
World (dis)ability Day 2020
PTC Therapeutics: avviata la sperimentazione della molecola PTC518 per il trattamento della malattia di Huntington
PTC Therapeutics has started in-human Huntington’s disease trial with PTC518
Malattia di Huntington: uno studio individua la relazione tra il riconoscimento delle emozioni e l’adeguatezza della scansione visiva
The emotions' recognition and the adequacy of visual scanning in a recent study on pre-manifest HD
Huntington’s Disease: Prilenia Enrolls First Patients into its PROOF-HD Trial
Huntington’s Disease: Prilenia Enrolls First Patients into PROOF-HD Clinical Trial
Molecola in corso di sperimentazione per la SMA sarà sperimentata anche nell'Huntington
Treatment for SMA could be used for Huntington’s disease: new trial planned for next year